Jack H. Jhamandas

Edmonton, AB, Canada

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 49 publications

Remembering Leo P. Renaud: Mentor, physiologist, friend.

Remembering Leo P. Renaud: Mentor, physiologist, friend.

Journal: Journal of neuroendocrinology
Published: December 03, 2025

Correction: Histamine induces the production of matrix metalloproteinase-9 in human astrocytic cultures via H1-receptor subtype.

Correction: Histamine induces the production of matrix metalloproteinase-9 in human astrocytic cultures via H1-receptor subtype.

Journal: Brain structure & function
Published: August 11, 2024

Bridging Integrator 1 (BIN1, rs6733839) and Sex Are Moderators of Vascular Health Predictions of Memory Aging Trajectories.

Bridging Integrator 1 (BIN1, rs6733839) and Sex Are Moderators of Vascular Health Predictions of Memory Aging Trajectories.

Journal: Journal of Alzheimer's disease : JAD
Published: July 24, 2022

Author Correction: Short amylin receptor antagonist peptides improve memory deficits in Alzheimer's disease mouse model.

Author Correction: Short amylin receptor antagonist peptides improve memory deficits in Alzheimer's disease mouse model.

Journal: Scientific reports
Published: April 28, 2022

Extracellular vesicles enriched with amylin receptor are cytoprotective against the Aß toxicity in vitro.

Extracellular vesicles enriched with amylin receptor are cytoprotective against the Aß toxicity in vitro.

Journal: PloS one
Published: November 04, 2021

Cyanidin-3-O-Glucoside improves the viability of human islet cells treated with amylin or Aβ1-42 in vitro.

Cyanidin-3-O-Glucoside improves the viability of human islet cells treated with amylin or Aβ1-42 in vitro.

Journal: PloS one
Published: May 25, 2021

Genetic Depletion of Amylin/Calcitonin Receptors Improves Memory and Learning in Transgenic Alzheimer's Disease Mouse Models.

Genetic Depletion of Amylin/Calcitonin Receptors Improves Memory and Learning in Transgenic Alzheimer's Disease Mouse Models.

Journal: Molecular neurobiology
Published: May 11, 2021

Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing.

Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing.

Journal: Nature reviews. Drug discovery
Published: June 03, 2020

Short amylin receptor antagonist peptides improve memory deficits in Alzheimer's disease mouse model.

Short amylin receptor antagonist peptides improve memory deficits in Alzheimer's disease mouse model.

Journal: Scientific reports
Published: March 06, 2019

Cyclic AC253, a novel amylin receptor antagonist, improves cognitive deficits in a mouse model of Alzheimer's disease.

Cyclic AC253, a novel amylin receptor antagonist, improves cognitive deficits in a mouse model of Alzheimer's disease.

Journal: Alzheimer's & dementia (New York, N. Y.)
Published: October 26, 2017

Role of microglial amylin receptors in mediating beta amyloid (Aβ)-induced inflammation.

Role of microglial amylin receptors in mediating beta amyloid (Aβ)-induced inflammation.

Journal: Journal of neuroinflammation
Published: May 15, 2017

Amylin Receptor: A Potential Therapeutic Target for Alzheimer's Disease.

Amylin Receptor: A Potential Therapeutic Target for Alzheimer's Disease.

Journal: Trends in molecular medicine
Published: April 24, 2017
Showing 1-12 of 49

Last Updated: 09/26/2026